Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

Related Citations for PubMed (Select 20388081)

1.

A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications.

Balistreri CR, Caruso C, Carruba G, Miceli V, Campisi I, Listì F, Lio D, Colonna-Romano G, Candore G.

Curr Pharm Des. 2010;16(6):718-24.

PMID:
20388081
2.

Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.

Stevens VL, Hsing AW, Talbot JT, Zheng SL, Sun J, Chen J, Thun MJ, Xu J, Calle EE, Rodriguez C.

Int J Cancer. 2008 Dec 1;123(11):2644-50. doi: 10.1002/ijc.23826.

PMID:
18752252
3.

Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.

Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ.

Cancer Res. 2005 Dec 15;65(24):11771-8.

4.

The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men.

Song J, Kim DY, Kim CS, Kim HJ, Lee DH, Lee HM, Ko W, Lee G.

Cancer Genet Cytogenet. 2009 Apr 15;190(2):88-92. doi: 10.1016/j.cancergencyto.2008.12.011.

PMID:
19380025
5.

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.

Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H.

J Natl Cancer Inst. 2005 Apr 6;97(7):525-32.

6.

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

Zheng SL, Augustsson-Bälter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Grönberg H.

Cancer Res. 2004 Apr 15;64(8):2918-22.

7.

CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.

Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Dahiya AV, Suehiro Y, Tanaka Y, Dahiya R.

Clin Cancer Res. 2007 Sep 1;13(17):5056-62.

8.

A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study.

Zheng SL, Liu W, Wiklund F, Dimitrov L, Bälter K, Sun J, Adami HO, Johansson JE, Sun J, Chang B, Loza M, Turner AR, Bleecker ER, Meyers DA, Carpten JD, Duggan D, Isaacs WB, Xu J, Grönberg H.

Prostate. 2006 Oct 1;66(14):1556-64.

PMID:
16921508
9.
10.

Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes.

Monroy CM, Cortes AC, Lopez MS, D'Amelio AM Jr, Etzel CJ, Younes A, Strom SS, El-Zein RA.

Mol Carcinog. 2011 Jan;50(1):36-46. doi: 10.1002/mc.20688.

PMID:
21061265
11.

ICAM gene cluster SNPs and prostate cancer risk in African Americans.

Chen H, Hernandez W, Shriver MD, Ahaghotu CA, Kittles RA.

Hum Genet. 2006 Aug;120(1):69-76. Epub 2006 May 30.

PMID:
16733712
12.

Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.

Danforth KN, Hayes RB, Rodriguez C, Yu K, Sakoda LC, Huang WY, Chen BE, Chen J, Andriole GL, Calle EE, Jacobs EJ, Chu LW, Figueroa JD, Yeager M, Platz EA, Michaud DS, Chanock SJ, Thun MJ, Hsing AW.

Carcinogenesis. 2008 Mar;29(3):568-72. Epub 2007 Nov 13.

13.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

14.

CCR5 proinflammatory allele in prostate cancer risk: a pilot study in patients and centenarians from Sicily .

Balistreri CR, Carruba G, Calabrò M, Campisi I, Di Carlo D, Lio D, Colonna-Romano G, Candore G, Caruso C.

Ann N Y Acad Sci. 2009 Feb;1155:289-92. doi: 10.1111/j.1749-6632.2008.03691.x.

PMID:
19250219
15.

Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk.

Amirian ES, Ittmann MM, Scheurer ME.

Prostate. 2011 Sep 15;71(13):1382-9. doi: 10.1002/pros.21354. Epub 2011 Feb 9.

PMID:
21308720
16.

Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.

Narita S, Tsuchiya N, Wang L, Matsuura S, Ohyama C, Satoh S, Sato K, Ogawa O, Habuchi T, Kato T.

Int J Cancer. 2004 Dec 10;112(5):872-6.

PMID:
15386377
17.

Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1993-7.

18.

Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population.

Terada N, Tsuchiya N, Ma Z, Shimizu Y, Kobayashi T, Nakamura E, Kamoto T, Habuchi T, Ogawa O.

Prostate. 2008 Nov 1;68(15):1689-95. doi: 10.1002/pros.20831.

PMID:
18726982
19.

Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer.

Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB.

Cancer Res. 2006 Apr 15;66(8):4525-30.

20.

Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.

Kwon EM, Salinas CA, Kolb S, Fu R, Feng Z, Stanford JL, Ostrander EA.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):923-33. doi: 10.1158/1055-9965.EPI-10-0994. Epub 2011 Mar 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk